Larisa Rudenko (Irina Isakova-Sivak)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Topics

Intellectual Disability

Protein Protein

Immune Response

Top Venues

Antibodies (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Overview of Nucleocapsid-Targeting Vaccines against COVID-19. Vaccines 11 (12) (2023)
Arina Goshina, Victoria Matyushenko, Daria Mezhenskaya, Alexandra Ya Rak, Anastasiia E Katelnikova, Denis Gusev, Larisa Rudenko, Irina Isakova-Sivak
RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples. Antibodies (Basel, Switzerland) 12 (2) (2023)
Arina Goshina, Victoria Matyushenko, Daria Mezhenskaya, Alexandra Ya Rak, Anastasiia E Katelnikova, Denis Gusev, Larisa Rudenko, Irina Isakova-Sivak
RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples. Antibodies (Basel, Switzerland) 12 (2) (2023)
Polina Prokopenko, Victoria Matyushenko, Alexandra Ya Rak, Ekaterina Stepanova, Anna Chistyakova, Arina Goshina, Igor Kudryavtsev, Larisa Rudenko, Irina Isakova-Sivak
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein. Vaccines 11 (3) (2023)
Alexandra Ya Rak, Irina Isakova-Sivak, Larisa Rudenko
Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines. Vaccines 11 (12) (2023)
Arina Goshina, Victoria Matyushenko, Daria Mezhenskaya, Alexandra Ya Rak, Anastasiia E Katelnikova, Denis Gusev, Larisa Rudenko, Irina Isakova-Sivak
RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples. Antibodies (Basel, Switzerland) 12 (2) (2023)
Polina Prokopenko, Victoria Matyushenko, Alexandra Ya Rak, Ekaterina Stepanova, Anna Chistyakova, Arina Goshina, Igor Kudryavtsev, Larisa Rudenko, Irina Isakova-Sivak
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein. Vaccines 11 (3) (2023)
Alexandra Ya Rak, Irina Isakova-Sivak, Larisa Rudenko
Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines. Vaccines 11 (12) (2023)
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Overview of Nucleocapsid-Targeting Vaccines against COVID-19. Vaccines 11 (12) (2023)
Igor Kudryavtsev, Artem A Rubinshtein, Alexey S Golovkin, Olga V Kalinina, Kirill A Vasilyev, Larisa Rudenko, Irina Isakova-Sivak
Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses 14 (5) (2022)
Igor Kudryavtsev, Victoria Matyushenko, Ekaterina Stepanova, Kirill A Vasilyev, Larisa Rudenko, Irina Isakova-Sivak
In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19. Vaccines 10 (9) (2022)
Alexandra Ya Rak, Svetlana Donina, Yana A Zabrodskaya, Larisa Rudenko, Larisa Rudenko
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests. Viruses 14 (9) (2022)
Daria Mezhenskaya, Irina Isakova-Sivak, Victoria Matyushenko, Svetlana Donina, Andrey Rekstin, Konstantin V Sivak, Kirill Yakovlev, Anastasiia E Katelnikova, Kirill Kryshen, Valery Makarov, Larisa Rudenko
Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge. Viruses 13 (7) (2021)
Ekaterina Stepanova, Elena Krutikova, Pei-Fong Wong, Victoria Matyushenko, Ekaterina A Bazhenova, Larisa Rudenko, Larisa Rudenko
Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model. Microorganisms 9 (2) (2021)
Ekaterina Stepanova, Victoria Matyushenko, Larisa Rudenko, Larisa Rudenko
Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus. Pathogens (Basel, Switzerland) 9 (6) (2020)
Tatiana Kotomina, Larisa Rudenko, Ki-Hye Kim, Bo Ryoung Park, Yu-Jin Jung, Youri Lee, Daria Mezhenskaya, Victoria Matyushenko, Sang-Moo Kang, Larisa Rudenko
Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes. Vaccines 8 (4) (2020)
Daniil Korenkov, Irina Isakova-Sivak, Larisa Rudenko
Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine. Expert review of vaccines 17 (11) (2018)
Tatiana Kotomina, Daniil Korenkov, Victoria Matyushenko, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak
Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site. Human vaccines & immunotherapeutics 14 (12) (2018)